Multidisciplinary Care and Supplemental Therapy in Clear-Cell RCC
Insight into the importance of patient-centered care, highlighting the role of a multidisciplinary team in managing advanced renal cell carcinoma and addressing questions regarding alternative medications.
Summary:
In the context of advanced renal cell carcinoma (RCC) treatment, a patient-centered approach is crucial, considering the overwhelming nature of a cancer diagnosis. The initial clinic visits are focused on understanding the patient’s emotional state, coping mechanisms, and comprehension of their diagnosis. Building a shared understanding between the healthcare team and the patient forms the foundation for informed decision-making.
The multidisciplinary team, comprising oncology nurse navigators, social workers, and pharmacists, plays a pivotal role in managing patients starting systemic therapy for kidney cancer. Emphasis is placed on the collaboration with pharmacists to navigate the complexities of adverse effects, especially when managing overlapping symptoms caused by tyrosine kinase inhibitors (TKIs) and immunotherapies. Addressing issues such as diarrhea, a common adverse effect, involves the expertise of the pharmacy team to differentiate contributing factors and tailor interventions. Supplement use, including herbal and alternative medications, is a common concern for patients seeking relief from cancer-related symptoms or adverse effects. The multidisciplinary approach allows for multiple clinicians to inquire about patient medications, ensuring a comprehensive understanding. Pharmacists engage in separate conversations, providing a dedicated space for patients to discuss alternative treatments. The team considers available data on drug interactions, toxicities, and expected adverse effects of herbal supplements. The cautious approach prioritizes patient safety, presenting data when available and allowing patients to continue certain supplements if deemed safe.
The multidisciplinary team’s collaboration extends to addressing questions about using supplements, recognizing potential drug interactions and liver metabolism issues. In-depth discussions help patients comprehend the totality of their care, fostering a collaborative decision-making process. Beyond medical interventions, the team considers quality of life, highlighting the importance of improving patient outcomes beyond survival metrics. The patient-centered, multidisciplinary approach not only addresses the complexities of advanced RCC treatment but also emphasizes the importance of considering the patient’s values and goals in shaping their care journey.
Summary is AI-generated and reviewed by Cancer Network editorial staff.
Hereditary Renal Tumor Syndromes and the Use of mTOR Inhibitors
A 47-year-old woman with a history of drug-resistant epilepsy during childhood presented to the emergency department with sudden dyspnea and chest pain. Upon admission, her oxygen saturation was 88%.
